Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration

Journal of Neuro-Ophthalmology

Volumn 30, Issue 2, 2010, Pages 205-

  Killer, Hanspeter E ^a,b   Jaggi, Gregor P ^a   Miller, Neil R ^c  

^a Kantonsspital Aarau ^*  (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSPINAL FLUID; CISTERNOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FENESTRATION; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LETTER; OPTIC NERVE DISEASE; OPTIC NERVE SHEATH FENESTRATION; OUTCOME ASSESSMENT; PAPILLEDEMA; PRIORITY JOURNAL; VISUAL DEPRIVATION; VISUAL FIELD; VISUAL IMPAIRMENT;

CEREBROSPINAL FLUID; DISEASE PROGRESSION; HUMANS; INTRACRANIAL HYPERTENSION; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPTIC NERVE; OPTIC NERVE DISEASES; PAPILLEDEMA; PATIENT SELECTION; RISK ASSESSMENT; SUBARACHNOID SPACE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953642854     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181d6f208     Document Type: Letter

References (4)

1. Wilkes BN, Siatkowski RM. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol. 2009;29:281-283.
2. Killer HE, Laeng HR, Flammer J, Groscurth P. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations. Br J Ophthalmol. 2003;87:777-781.
3. Xin X, Huber A, Meyer P, Flammer J, Neutzner A, Miller NR, Killer HE. L-PGDS (betatrace protein) inhibits astrocyte proliferation and mitochondrial ATP production in vitro. J Mol Neurosci. 2009;39:366-371.
4. Killer HE, Jaggi GP, Miller NR. Papilledema revisited: is its pathophysiology really understood? Clin Experiment Ophthalmol. 2009;37:444-447.